To validate the role of PD-L1 in cetuximab sensitivity to CRC, PD-L1 knockout (KO) cell lines (SW480-KO and LoVo-KO) were generated from CRC cell lines (SW480 and LoVo). The gene discussed is CD274; the disease is colorectal carcinoma.